Released Jan 23, 2024, after the close
10-K filed Jan 31, 2024, 31 days after period end · 0001035267-24-000021
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.93B$1.93B derived+16.5% vs Q4 2022+10.6% vs Q3 2023
Net Income$606.20M$606.20M derived+86.6% vs Q4 2022+45.8% vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,277,400,000+15.0%
Operating Incomederived$450,200,000+20.9%
Operating Cash Flowderived$228,300,000−47.9%
Free Cash Flowderived-$207,200,000N/M
Margins · derived
Gross margin66.2%−0.9 pt vs Q4 2022
Operating margin23.3%+0.8 pt vs Q4 2022
Net margin31.4%+11.8 pt vs Q4 2022
What the release said
The release
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $1.93B | $1.66B | $1.55B | $1.33B |
| Net Income | $606.20M | $324.90M | $380.60M | $365.20M |
| EPS Diluted | — | — | $1.03 | $3.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR